Clinical trials
Terminated Uterine Cervical Neoplasms trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2011 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Seagen Inc. | 3 |
| Incyte Corporation | 2 |
| Amgen | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
| Hoffmann-La Roche | 1 |
| Iovance Biotherapeutics, Inc. | 1 |
| Kymab Limited | 1 |
| Royal Marsden NHS Foundation Trust | 1 |
| Seagen, a wholly owned subsidiary of Pfizer | 1 |
| Sheffield Teaching Hospitals NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Neoplasms | 13 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Ovarian Neoplasms | 5 |
| Stomach Neoplasms | 4 |
| Carcinoma, Renal Cell | 3 |
| Endometrial Neoplasms | 3 |
| Melanoma | 3 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Triple Negative Breast Neoplasms | 3 |
| Adenocarcinoma, Mucinous | 2 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.